In PD-1 gene-deficient or PD-L1 genes inhibited by antibodies in animal models, it has been observed the development of autoimmune diseases and cardiomyopathies, the onset of diabetes, alteration of thymic T-cells, and impaired feta maternal tolerance [2,3,4,5,6]. This evidence concerns the gene PDCD1 and cardiomyopathy.